Tongguan Tian
Tongji University(CN)Tongji Hospital(CN)
Publications by Year
Research Areas
Epigenetics and DNA Methylation, Extracellular vesicles in disease, MicroRNA in disease regulation, Cancer Immunotherapy and Biomarkers, Renal cell carcinoma treatment
Most-Cited Works
- → D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1(2022)225 cited
- → TET2 Suppresses VHL Deficiency-Driven Clear Cell Renal Cell Carcinoma by Inhibiting HIF Signaling(2022)66 cited
- → FTY720 attenuates behavioral deficits in a murine model of systemic lupus erythematosus(2018)42 cited
- → TET2 is required to suppress mTORC1 signaling through urea cycle with therapeutic potential(2023)24 cited
- → FBXO38 mediates FGL1 ubiquitination and degradation to enhance cancer immunity and suppress inflammation(2023)19 cited
- → Antihypertensive and antioxidant effects of food‐derived bioactive peptides in spontaneously hypertensive rats(2024)18 cited
- → Discovery of extracellular vesicle-delivered miR-185-5p in the plasma of patients as an indicator for advanced adenoma and colorectal cancer(2023)16 cited
- → p53 inhibits OTUD5 transcription to promote GPX4 degradation and induce ferroptosis in gastric cancer(2025)14 cited
- → Silencing LncRNA SNHG14 alleviates renal tubular injury via the miR-483-5p/HDAC4 axis in diabetic kidney disease(2024)8 cited
- → Dysregulation of miR-25-3p in Diabetic Nephropathy and Its Role in Inflammatory Response(2024)4 cited